Exact Mass: 478.183888
Exact Mass Matches: 478.183888
Found 271 metabolites which its exact mass value is equals to given mass value 478.183888
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Enterodiol glucuronide
Clobetasone butyrate
Ethyl 4-(3,4-dimethoxyphenyl)-6,7-dimethoxy-2-(1H-1,2,4-triazol-1-ylmethyl)-3-quinolinecarboxylate
Calcium pantothenate
Nutrient supplement, may be used in infant formulas. Enzyme cofactor vitamin. Pantothenic acid is a water-soluble vitamin. For many animals, pantothenic acid is an essential nutrient. Only the dextrorotatory (D) isomer of pantothenic acid possesses biologic activity. The levorotatory (L) form may antagonize the effects of the dextrorotatory isomer. Nutrient supplement, may be used in infant formulas. Enzyme cofactor vitamin
(2S)-7-hydroxy-8-hydroxyethyl-4-methoxyflavane-2-O-beta-D-glucopyranoside|7,2-dihydroxy-8-hydroxyethyl-4-methoxyflavane-2-O-beta-D-glucopyranoside
(2S)-7-methoxy-8-hydroxyethyl-4-hydroxyflavane-2-O-beta-D-glucopyranoside
10alpha-acetoxy-8alpha-methacroyloxy-1alpha-methoxyhirsutinolide-13-O-acetate
6beta,9beta-diacetoxy-4(15)-en-1alpha,10alpha-epoxy-5alpha-(2-methylbutyryloxy)-2-oxo-7,8alpha-germacranolide
(2E)-3-phenylprop-2-enoic acid [(1S,4aR,5S,7aS,)-1-(beta-D-glucopyranosyloxy)-1,3-4,4a,5,7a-hexahydro-5-hydroxycyclopenta[c]pyran-7-yl]methyl ester|sintenoside
2alpha,13-diacetoxy-8alpha-angeloyloxy-4alpha,14-dihydroxygermacra-1(10)E,5E,7(11)-trien-12,6-olide
(7R,8R)-3-methoxyl-9-O-beta-D-xylopyranosyl-4:7,5:8-diepoxyneodiepoxyneolignan-4,9-diol
(2E)-3-phenylprop-2-enoic acid rel-(1R,4aR,7R,7aR)-1-(beta-D-glucopyranosyloxy)-1,4a,5,6,7,7a-hexahydro-4a-hydroxy-7-methylcylopenta[c]pyran-7-yl ester|6-deoxyharpagoside|corvifloruside E
(3aR,4S,5aR,6R,9R,9bR)-9-formyldodecahydro-6-hydroxy-5a-methyl-3-methylidene-2-oxonaphtho[1,2-b]furan-4-yl 4-(acetyloxy)-2-[(acetyloxy)methyl]but-2-enoate|8alpha-O-(4,5-diacetoxyangeloyl)sonchucarpolide
3-alpha-acetoxymaoesin A|3alpha,19-diacetoxy-6alpha,20-dihydroxy-6,11beta-epoxy-15-oxo-6,7-seco-ent-kaur-16-en-1beta,7-olide
(5S)-1,7-bis(3,4-dihydroxyphenyl)-5-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyheptan-3-one
(2S,3R,4S,5R)-2-[4-[7-hydroxy-3-(hydroxymethyl)-5-(3-hydroxypropyl)-2,3-dihydro-1-benzofuran-2-yl]-2-methoxyphenoxy]oxane-3,4,5-triol
(2S,3R,4S,5R)-2-[4-[7-hydroxy-3-(hydroxymethyl)-5-(3-hydroxypropyl)-2,3-dihydro-1-benzofuran-2-yl]-2-methoxyphenoxy]oxane-3,4,5-triol
(5S)-1,7-bis(3,4-dihydroxyphenyl)-5-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyheptan-3-one [IIN-based: Match]
8-2-Amino-3,8-dimmethylimidazo[4,5-f]quinoxaline-deoxyguanosine
(2S,3R,4S,5R)-2-[4-[7-hydroxy-3-(hydroxymethyl)-5-(3-hydroxypropyl)-2,3-dihydro-1-benzofuran-2-yl]-2-methoxyphenoxy]oxane-3,4,5-triol_major
Ala Asp His His
Ala His Asp His
Ala His His Asp
Cys Asp Lys Asn
Cys Asp Asn Lys
Cys Lys Asp Asn
Cys Lys Asn Asp
Cys Asn Asp Lys
Cys Asn Lys Asp
Cys Pro Pro Tyr
Cys Pro Tyr Pro
Cys Gln Gln Thr
Cys Gln Thr Gln
Cys Thr Gln Gln
Cys Tyr Pro Pro
Asp Ala His His
Asp Cys Lys Asn
Asp Cys Asn Lys
Asp His Ala His
Asp His His Ala
Asp Lys Cys Asn
Asp Lys Asn Cys
Asp Asn Cys Lys
Asp Asn Lys Cys
Glu Glu Thr Thr
Glu Gly His His
Glu His Gly His
Glu His His Gly
Glu Thr Glu Thr
Glu Thr Thr Glu
Gly Glu His His
Gly His Glu His
Gly His His Glu
His Ala Asp His
His Ala His Asp
His Asp Ala His
His Asp His Ala
His Glu Gly His
His Glu His Gly
His Gly Glu His
His Gly His Glu
His His Ala Asp
His His Asp Ala
His His Glu Gly
His His Gly Glu
Lys Cys Asp Asn
Lys Cys Asn Asp
Lys Asp Cys Asn
Lys Asp Asn Cys
Lys Asn Cys Asp
Lys Asn Asp Cys
Clobetasone butyrate
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D000893 - Anti-Inflammatory Agents
Met Met Pro Thr
Met Met Thr Pro
Met Asn Asn Thr
Met Asn Gln Ser
Met Asn Ser Gln
Met Asn Thr Asn
Met Pro Met Thr
Met Pro Thr Met
Met Gln Asn Ser
Met Gln Ser Asn
Met Ser Asn Gln
Met Ser Gln Asn
Met Thr Met Pro
Met Thr Asn Asn
Met Thr Pro Met
Asn Cys Asp Lys
Asn Cys Lys Asp
Asn Asp Cys Lys
Asn Asp Lys Cys
Asn Lys Cys Asp
Asn Lys Asp Cys
Asn Met Asn Thr
Asn Met Gln Ser
Asn Met Ser Gln
Asn Met Thr Asn
Asn Asn Met Thr
Asn Asn Thr Met
Asn Gln Met Ser
Asn Gln Ser Met
Asn Ser Met Gln
Asn Ser Gln Met
Asn Thr Met Asn
Asn Thr Asn Met
Pro Cys Pro Tyr
Pro Cys Tyr Pro
Pro Met Met Thr
Pro Met Thr Met
Pro Pro Cys Tyr
Pro Pro Tyr Cys
Pro Thr Met Met
Pro Tyr Cys Pro
Pro Tyr Pro Cys
Gln Cys Gln Thr
Gln Cys Thr Gln
Gln Met Asn Ser
Gln Met Ser Asn
Gln Asn Met Ser
Gln Asn Ser Met
Gln Gln Cys Thr
Gln Gln Thr Cys
Gln Ser Met Asn
Gln Ser Asn Met
Gln Thr Cys Gln
Gln Thr Gln Cys
Ser Met Asn Gln
Ser Met Gln Asn
Ser Asn Met Gln
Ser Asn Gln Met
Ser Gln Met Asn
Ser Gln Asn Met
Thr Cys Gln Gln
Thr Glu Glu Thr
Thr Glu Thr Glu
Thr Met Met Pro
Thr Met Asn Asn
Thr Met Pro Met
Thr Asn Met Asn
Thr Asn Asn Met
Thr Pro Met Met
Thr Gln Cys Gln
Thr Gln Gln Cys
Thr Thr Glu Glu
Tyr Cys Pro Pro
Tyr Pro Cys Pro
Tyr Pro Pro Cys
Silatecan
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor
3-[[(4-chlorophenyl)methyl-[(5-nitrothiophen-2-yl)methyl]amino]methyl]-N-pentylpyrrolidine-1-carboxamide
Ethyl 4-(3,4-dimethoxyphenyl)-6,7-dimethoxy-2-(1H-1,2,4-triazol-1-ylmethyl)-3-quinolinecarboxylate
1,4-Bis[2-(4-hydroxyphenyl)ethylamino]anthracene-9,10-dione
C30H26N2O4 (478.18924760000004)
JFD00244 is a sirtuin 2 (SIRT2) inhibitor, with anti-tumor effect. JFD00244 is also a Nsp-16 inhibitor against SARS-CoV-2[1][2].
1-(3-Ethoxypropyl)-2-[2-furanyl(oxo)methyl]imino-10-methyl-5-oxo-3-dipyrido[3,4-c:1,2-f]pyrimidinecarboxylic acid ethyl ester
Phenylalanylaminodi(ethyloxy)ethyl benzenesulfonamideaminocarbonylbenzenesulfonamide
2-[4-[7-Hydroxy-3-(hydroxymethyl)-5-(3-hydroxypropyl)-2,3-dihydro-1-benzofuran-2-yl]-2-methoxyphenoxy]oxane-3,4,5-triol
1,7-Bis(3,4-dihydroxyphenyl)-5-(3,4,5-trihydroxyoxan-2-yl)oxyheptan-3-one
(2r)-2-[[(1r,2s,3r,4r,5r)-4-Acetamido-2-[(2s,3r,4r,5s,6r)-3-Acetamido-6-(Hydroxymethyl)-4,5-Bis(Oxidanyl)oxan-2-Yl]oxy-6,8-Dioxabicyclo[3.2.1]octan-3-Yl]oxy]propanoic Acid
Calcium;3-[(2,4-dihydroxy-3,3-dimethylbutanoyl)amino]propanoic acid
3alpha-Acetoxymaoesin A, (rel)-
A natural product found in Isodon eriocalyx.
N-(3-dibenzofuranyl)-2-[2-oxo-2-(2,4,6-trimethylanilino)ethoxy]benzamide
C30H26N2O4 (478.18924760000004)
N-[2-chloro-5-[ethyl(phenyl)sulfamoyl]phenyl]-2-[methyl-(1-methyl-4-piperidinyl)amino]acetamide
N-[2-[1,3-benzodioxol-5-yl-[2-(tert-butylamino)-2-oxo-1-pyridin-4-ylethyl]amino]-2-oxoethyl]-2-furancarboxamide
N-[3-[4-(4-chlorophenyl)piperazin-1-yl]propyl]-2-(7-oxo-2,8,10-triazatricyclo[7.4.0.02,6]trideca-1(9),3,5,10,12-pentaen-8-yl)acetamide
(2S,3S,5S)-2-[[2-(3,4-dimethoxyphenyl)-7-methoxy-3,4-dihydro-2H-chromen-5-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
3-[4-[(2S,3S,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-1-(2,4,6-trimethoxyphenyl)propan-1-one
N2-(Deoxyguanosin-8-yl)-2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline
2-Methoxy-4-[2,3-dihydro-3-(hydroxymethyl)-5-(3-hydroxypropyl)-7-hydroxybenzofuran-2-yl]phenyl beta-D-xylopyranoside
YG1702
YG1702 is a potent ALDH18A1-specific inhibitor. YG1702 attenuates the growth of MYCN-amplified NB and down-regulates MYCN. YG1702 physically interacts with ALDH18A1 with a high affinity and might potentially affect its enzymatic activity[1].
(2s,3r,4s,5s,6r)-2-{2-[(2s)-7-hydroxy-8-(2-hydroxyethyl)-3,4-dihydro-2h-1-benzopyran-2-yl]-5-methoxyphenoxy}-6-(hydroxymethyl)oxane-3,4,5-triol
methyl (3ar,4s,5r,8r,11ar)-8-hydroxy-10-(hydroxymethyl)-3-methylidene-5-[(2-methylprop-2-enoyl)oxy]-4-[(2-methylpropanoyl)oxy]-2-oxo-3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-6-carboxylate
(1s,5r,7s,7as)-5-hydroxy-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-7-yl (2e)-3-phenylprop-2-enoate
1,7-bis(3,4-dihydroxyphenyl)-5-[(3,4,5-trihydroxyoxan-2-yl)oxy]heptan-3-one
2,10-bis(acetyloxy)-3-methyl-8,12-dimethylidene-6,13-dioxo-4,14-dioxatricyclo[9.3.0.0³,⁵]tetradecan-9-yl 2-methylbutanoate
2-{[2-(3,4-dimethoxyphenyl)-7-methoxy-3,4-dihydro-2h-1-benzopyran-5-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
1-{2-[2-(3,4-dimethoxyphenyl)ethyl]-6-hydroxy-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl}ethanone
(1r,2s,3r,5r,9r,10r,11r)-2,10-bis(acetyloxy)-3-methyl-8,12-dimethylidene-6,13-dioxo-4,14-dioxatricyclo[9.3.0.0³,⁵]tetradecan-9-yl (2r)-2-methylbutanoate
(2s,3r,4s,5s,6r)-2-{[(2s)-2-(3,4-dimethoxyphenyl)-7-methoxy-3,4-dihydro-2h-1-benzopyran-5-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
8-(acetyloxy)-12-[(acetyloxy)methyl]-4,8-dimethyl-7,13-dioxo-3,14-dioxatricyclo[9.3.0.0²,⁴]tetradec-11-en-10-yl 2-methylbut-2-enoate
(2r,3r,4s,5s,6s)-2-(hydroxymethyl)-6-[(3,5,6,7-tetramethoxy-9,10-dihydrophenanthren-2-yl)oxy]oxane-3,4,5-triol
(2s,3s,4s,5s,6s)-2-{[(2r)-2-(3,4-dimethoxyphenyl)-7-methoxy-3,4-dihydro-2h-1-benzopyran-5-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2r,3r,4s,5s,6r)-2-{2-[(2s)-7-hydroxy-8-(2-hydroxyethyl)-3,4-dihydro-2h-1-benzopyran-2-yl]-5-methoxyphenoxy}-6-(hydroxymethyl)oxane-3,4,5-triol
8-cinnamoylmyoporoside
{"Ingredient_id": "HBIN013689","Ingredient_name": "8-cinnamoylmyoporoside","Alias": "NA","Ingredient_formula": "C24H30O10","Ingredient_Smile": "CC1(CC(C2C1C(OC=C2)OC3C(C(C(C(O3)CO)O)O)O)O)OC(=O)C=CC4=CC=CC=C4","Ingredient_weight": "478.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "3711","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101402540","DrugBank_id": "NA"}